T1	DRUG 29 35	サラゾビリン
T2	DRUG 63 69	ミナルフェン
T3	DRUG 172 177	プレドニン
T4	DRUG 309 315	サラゾピリン
T5	DISORDER 18 24	潰瘍性大腸炎
T6	DISORDER 44 49	全身倦怠感
T7	DISORDER 50 52	発熱
T8	DISORDER 53 55	腰痛
T9	DISORDER 82 87	浮腫性紅斑
T10	DISORDER 109 114	緊満性水疱
T11	DISORDER 129 131	高熱
T12	DISORDER 132 138	リンパ節腫大
T13	DISORDER 139 144	白血球増多
T14	DISORDER 162 167	肝機能障害
T15	DISORDER 187 189	皮疹
T16	DISORDER 213 216	核異常
T17	DISORDER 257 265	多形滲出性紅斑像
T18	DISORDER 269 275	異型リンパ球
T19	DISORDER 290 296	悪性リンパ腫
T20	DISORDER 317 326	伝染性単核症型薬疹
T21	TEST 233 236	ＬＤＨ
T23	DISORDER 276 278	浸潤
T24	TEST 145 148	ＧＯＴ
T25	TEST 153 156	ＬＤＨ
T26	TEST 251 255	皮膚生検
T27	TEST 282 288	リンパ節生検
T28	MEASURE 177 181	６０ｍｇ
T29	MEASURE 156 160	１０２８
T30	MEASURE 149 152	１４７
T31	MEASURE 205 208	約４万
T32	MEASURE 226 231	最高１６％
T33	ANATOMY 79 81	顔面
T34	ANATOMY 99 101	全身
T35	ANATOMY 105 107	四肢
T36	DRUG 335 337	同剤
T37	TEST 338 343	内服テスト
T38	MEASURE 351 353	陽性
T43	CHANGE_TRIGGER 181 185	投与開始
T44	CHANGE_TRIGGER 35 39	内服開始
T45	CHANGE_TRIGGER 69 71	追加
T47	PERSONAL_INFORMATION 0 3	４７歳
T48	PERSONAL_INFORMATION 4 5	女
T49	TIME 7 18	平成２年５月１７日より
T50	TIME 40 44	６月初旬
T51	TIME 59 63	６月８日
T52	TIME 190 195	約２週後に
T53	TIME 240 246	７月下旬まで
A1	Temporality T50 date
A2	Temporality T51 date
A3	Temporality T52 duration
T39	TEST 201 204	白血球
T41	OPINION 195 197	略治
T46	TIME 91 99	２～３日のうちに
T55	TIME 75 78	１２日
A5	Temporality T55 date
T56	TIME 123 126	１８日
A6	Temporality T56 date
A7	Sentiment T41 positive
T57	ANATOMY 219 223	リンパ球
A8	Temporality T53 duration
R1	TREATMENT_FOR Arg1:T1 Arg2:T5	
R3	SIGNALS_CHANGE_OF Arg1:T44 Arg2:T1	
A9	Drug_Changes T1 started
R4	HAS_TIME Arg1:T1 Arg2:T49	
R5	HAS_TIME Arg1:T6 Arg2:T50	
R6	HAS_TIME Arg1:T7 Arg2:T50	
R7	HAS_TIME Arg1:T8 Arg2:T50	
R8	SIGNALS_CHANGE_OF Arg1:T45 Arg2:T2	
A10	Drug_Changes T2 started
R9	HAS_TIME Arg1:T2 Arg2:T51	
R10	EXPERIENCED_IN Arg1:T9 Arg2:T33	
R11	HAS_TIME Arg1:T9 Arg2:T55	
R12	EXPERIENCED_IN Arg1:T9 Arg2:T34	
R14	EXPERIENCED_IN Arg1:T9 Arg2:T35	
R15	EXPERIENCED_IN Arg1:T10 Arg2:T35	
R16	HAS_RESULT Arg1:T25 Arg2:T29	
R17	HAS_RESULT Arg1:T24 Arg2:T30	
R18	SIGNALS_CHANGE_OF Arg1:T43 Arg2:T3	
A4	Drug_Changes T3 started
R19	HAS_DOSAGE Arg1:T3 Arg2:T28	
R20	TREATMENT_FOR Arg1:T3 Arg2:T14	
R21	HAS_TIME Arg1:T15 Arg2:T52	
R22	IS_OPINION_ABOUT Arg1:T41 Arg2:T15	
R24	EXPERIENCED_IN Arg1:T16 Arg2:T57	
R26	HAS_TIME Arg1:T16 Arg2:T53	
R27	HAS_RESULT Arg1:T26 Arg2:T17	
R28	HAS_RESULT Arg1:T26 Arg2:T18	
R29	HAS_RESULT Arg1:T26 Arg2:T23	
R30	HAS_RESULT Arg1:T27 Arg2:T19	
R31	HAS_RESULT Arg1:T37 Arg2:T38	
R32	REFERS_TO Arg1:T36 Arg2:T4	
R33	MISC Arg1:T37 Arg2:T36	
R34	REFERS_TO Arg1:T15 Arg2:T9	
R35	REFERS_TO Arg1:T15 Arg2:T10	
A13	Temporality T46 duration
R37	HAS_TIME Arg1:T11 Arg2:T56	
R38	HAS_TIME Arg1:T12 Arg2:T56	
R39	HAS_TIME Arg1:T13 Arg2:T56	
R40	HAS_TIME Arg1:T14 Arg2:T56	
R41	HAS_TIME Arg1:T3 Arg2:T56	
T22	OPINION 210 212	増加
T40	OPINION 237 239	上昇
R23	HAS_RESULT Arg1:T39 Arg2:T31	
R25	MISC Arg1:T22 Arg2:T39	
R42	HAS_RESULT Arg1:T40 Arg2:T21	
R36	CAUSED Arg1:T4 Arg2:T20	
R44	TREATMENT_FOR Arg1:T2 Arg2:T8	
R45	TREATMENT_FOR Arg1:T2 Arg2:T7	
R43	MISC Arg1:T40 Arg2:T53	
R46	EXAMINED_WITH Arg1:T15 Arg2:T26	
A11	Sentiment T22 negative
A12	Sentiment T40 negative
R2	HAS_TIME Arg1:T10 Arg2:T46	
R13	MISC Arg1:T55 Arg2:T46	
R47	MISC Arg1:T55 Arg2:T52	
